CClinicalTrials.gg
Active, not recruitingNCT06905769Updated Apr 1, 2025

Effects of Aquatic Therapy Versus Neuro-dynamic Technique for the Treatment of Carpal Tunnel Syndrome Patient

An interventional study of Aquatic Therapy and Neuro-Dynamic Technique in Carpal Tunnel Syndrome, sponsored by Superior University. Active, not recruiting at 1 site in Pakistan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-01.

Sponsored by Superior University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 3 months ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Carpal Tunnel Syndrome (CTS) is a common neurological disorder due to entrapment of median nerve which runs from the forearm into the hand through a tunnel, compressed or pinched due to anatomical factors, such as a narrow carpal tunnel. Widespread condition that affects 3-6% of the general population worldwide. Carpal Tunnel Syndrome (CTS) a prevalent and debilitating condition leading to disability despite optimal interventions to rehabilitation that aimed to reducing pain and improving neural function status in Carpal Tunnel Syndrome Patients .

Read the detailed description

This study investigates the additional benefits of Aquatic Therapy and Neuro-dynamic Technique in Carpal Tunnel Syndrome Patients .The researcher employs a randomized controlled trial methodology. Participants are divided into two groups: one receiving Aquatic Therapy, and the other receiving Neuro-dynamic Technique.

Outcomes are assessed over an 8-week period, focusing on pain levels and neural function restoration and grip strength. The significance of this study lies in its potential to enhance current treatment protocols, offering a more effective, intervention to alleviate symptoms and improve the quality of life, neural restoration for those suffering Carpal Tunnel Syndrome (CTS).

02

Conditions studied

  • Carpal Tunnel Syndrome
03

In context

Carpal Tunnel Syndrome

589 studies on the registry are indexed under Carpal Tunnel Syndrome; 139 are open to participants now.

This study's enrollment of 30 is below the median of 60 across 445 interventional studies indexed under Carpal Tunnel Syndrome.

Browse Carpal Tunnel Syndrome studies →

Lead sponsor

Superior University is the lead sponsor of 242 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosed with mild-to-moderate carpal tunnel syndrome by Neuromuscular Physician
  • Participants who presented with unilateral CTS with symptoms reported up to 3 months
  • Male and female
  • Aged 18 years or older

Exclusion criteria

Exclusion Criteria:

  • Patients with non-specified stage of CTS,median nerve entrapment in TOS, Cervical Radiculpathy
  • Participants presents with co-morbidities,Hx of CTS (e.g., pregnancy, diabetes, trauma, congenital disorders, obesity, post-surgical release, and hypothyroidism)
  • Cardiovascular disease, thenar muscle atropy"
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Aquatic Therapy

    Combination Product: Aquatic Therapy

  • Experimental
    Neuro-Dynamic Technique

    Diagnostic Test: Neuro-Dynamic Technique

Interventions

  • Combination productAquatic Therapy

    Group A was treated with Aquatic Therapy for 30-45 minutes for 3 sessions per week for 8 weeks . Patient should Seated .Therapist will standing or seated beside the patient Therapist Perform gentle stretching on wrist, hand, and finger joints. Exercises to improve range of motion and reduce stiffness. Then perform aquatic therapy for 10 minutes. Therapist instruct patients hands in bath tube. Water temperature 88°F - 94°F (31°C - 34°C).Water depth is Waist-deep or deeper depending on patient comfort

  • Diagnostic testNeuro-Dynamic Technique

    Group B (Neuro-Dynamic Technique) Group B was treated with Neuro-Dynamic Technique for 15 minutes 3 sessions per week for 8 weeks. Patient should Seated or supine with the affected hand relaxed. Therapist will standing or seated beside the patient. Techniques Time duration is 3 minutes for each technique. wrist distraction 3 sets for 3 minute rhythmic and gentle stretching of the transverse carpel ligament Release of palmar fascia gliding of finger flexor tendons release of upper forearm muscle and fascia.

06

What researchers measure

Primary outcomes

  1. NUMERIC PAIN RATING SCALE (NPRS)

    The 11-point numeric scale ranges from '0' representing "no pain" to '10' representing "pain as bad as you can imagine" or "worst pain imaginable". The NPRS is a valid and reliable scale to measure pain intensity. NPRS demonstrates strong correlation validity with other established pain measurement scales, making it a reliable tool for clinical assessments.

    Time frame: 12 Months

  2. Boston Carpal Tunnel Questionnaire (BCTQ)

    The questionnaire has been designed to evaluate Assess the severity of CTS symptoms and functional impairment. The total number of questions is 19, total score is 95(sum of 2 subscales) in the BCTQ. Symptom Severity Scale (SSS): 11 items assessing the severity of CTS symptoms, such as numbness, tingling, and pain. Functional Status Scale (FSS) 8 items evaluating the impact of CTS on daily activities, such as grasping, gripping, an carrying. Symptom Severity Scale (SSS): Scores range from 1-5, with higher scores indicating more severe symptoms Functional Status Scale (FSS): Scores range from 1-5, with higher scores indicating greater functional impairment .Reliability 0.95% and Validity 0.80%. Interpretation Symptom Severity Scale (SSS) Mild symptoms: 1-2 Moderate symptoms: 2-3 Severe symptoms: 3-4 Very severe symptoms: 4-5

    Time frame: 12 Months

  3. Grip Strength

    Digital Hand Dynamometer is a device used to measure grip strength, which is the force exerted by the hand when grasping an object. Hand Dynamometer units of measurement typically represents the maximum grip strength measured in units Kilograms (kg),Pounds (lb) And Newtons (N). Standard-range dynamometers: 0-100 kg (0-220 lb). Normal Values for Grip Strength Adult Men: 35-55 kg Adult Women: 20-35 kg Interpretation Mild Weakness: 10-20% below normal range. Moderate Weakness: 20-40% below normal range. Severe Weakness: 40-60% below normal range. Profound Weakness: More than 60% below normal range."

    Time frame: 12 Months

07

Study locations

1 site
  • Superior University CRC
    Lahore, Punjab, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06905769
Lead sponsor
Superior University
Responsible party
Muhammad Naveed Babur (Principal Investigator, Superior University) — Principal investigator
First posted
Apr 1, 2025
Start date
Mar 20, 2025
Primary completion
Jun 20, 2025 (estimated)
Completion
Feb 20, 2026 (estimated)
Last update
Apr 1, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion